Novavax announces efficacy of about 90% for its vaccine Subject : Science & tech Context: U.S. vaccine manufacturer Novavax said its COVID-19 vaccine had shown an overall efficacy of 90.4% in trials in the U.S. and Mexico, potentially adding — in a few months — another vaccine to the world’s arsenal against the […]